Cohen Klingenstein’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Hold
30,500
0.04% 145
2026
Q1
$1.91M Hold
30,500
0.06% 123
2025
Q4
$2.91M Hold
30,500
0.09% 91
2025
Q3
$2.98M Hold
30,500
0.09% 92
2025
Q2
$3.28M Hold
30,500
0.11% 88
2025
Q1
$3.08M Hold
30,500
0.11% 86
2024
Q4
$2.72M Hold
30,500
0.09% 94
2024
Q3
$2.56M Hold
30,500
0.09% 117
2024
Q2
$2.35M Hold
30,500
0.09% 115
2024
Q1
$2.09M Hold
30,500
0.08% 128
2023
Q4
$1.76M Hold
30,500
0.07% 133
2023
Q3
$1.61M Hold
30,500
0.07% 134
2023
Q2
$1.65M Hold
30,500
0.07% 133
2023
Q1
$1.53M Hold
30,500
0.07% 138
2022
Q4
$1.41M Hold
30,500
0.07% 142
2022
Q3
$1.18M Hold
30,500
0.06% 145
2022
Q2
$1.14M Hold
30,500
0.06% 150
2022
Q1
$1.35M Hold
30,500
0.06% 151
2021
Q4
$1.3M Hold
30,500
0.05% 154
2021
Q3
$1.32M Hold
30,500
0.06% 153
2021
Q2
$1.3M Hold
30,500
0.06% 162
2021
Q1
$1.18M Hold
30,500
0.05% 166
2020
Q4
$1.1M Hold
30,500
0.05% 164
2020
Q3
$1.17M Hold
30,500
0.07% 149
2020
Q2
$1.07M Hold
30,500
0.07% 153
2020
Q1
$995K Hold
30,500
0.07% 144
2019
Q4
$1.38M Hold
30,500
0.08% 136
2019
Q3
$1.24M Buy
+30,500
New +$1.29M 0.08% 139

Other funds holding BSX

Cohen Klingenstein's BSX Position: Q2 2026 in Review

Cohen Klingenstein held its Boston Scientific (BSX) position steady in Q2 2026 at 30,500 shares worth $1.3M. The position accounts for 0.04% of the portfolio, ranked #145.

Cohen Klingenstein first reported a position in BSX in Q3 2019 and has held it in 28 quarters since. The position peaked at $3.28M in Q2 2025. 495 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cohen Klingenstein held 30,500 shares of Boston Scientific worth $1.3M as of Q2 2026.
  • Cohen Klingenstein left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.04% of Cohen Klingenstein's portfolio in Q2 2026, its #145 holding.
  • Cohen Klingenstein first reported a position in Boston Scientific in Q3 2019 and has held it in 28 quarters since.
  • Cohen Klingenstein's Boston Scientific position peaked at $3.28M in Q2 2025.
  • 495 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.